Skip to content
← Full study record

NCT01265433 · MORE INFO

Limitations, agreements, and source contact

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy · Source last updated 2024-10-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
info@sellaslife.com
organization
Sellas Life Sciences
phone
646-200-5278
title
Dr. Dragan Cicic
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
info@sellaslife.com
organization
Sellas Life Sciences
phone
646-200-5278
title
Dr. Dragan Cicic

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice